Anchyra Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$270K Buy
9,477
+120
+1% +$3.19K 0.06% 303
2026
Q2
$225K Sell
9,357
-2,532
-21% -$66.2K 0.05% 290
2026
Q1
$334K Buy
11,889
+986
+9% +$26.3K 0.1% 195
2025
Q4
$271K Buy
+10,903
New +$275K 0.08% 212

Other funds holding PFE

Anchyra Partners's PFE Position: Q3 2026 in Review

Anchyra Partners increased its Pfizer (PFE) stake by 1.3% in Q3 2026, buying an estimated $3.19K and bringing the position to 9,477 shares worth $270K. The position accounts for 0.06% of the portfolio, ranked #303.

Anchyra Partners first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. The position peaked at $334K in Q1 2026. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Anchyra Partners held 9,477 shares of Pfizer worth $270K as of Q3 2026.
  • Anchyra Partners bought 120 Pfizer shares in Q3 2026, an estimated $3.19K.
  • Pfizer made up 0.06% of Anchyra Partners's portfolio in Q3 2026, its #303 holding.
  • Anchyra Partners first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
  • Anchyra Partners's Pfizer position peaked at $334K in Q1 2026.
  • 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.